T1	Participants 415 478	patients with liver cirrhosis secondary to chronic hepatitis B.
T2	Participants 498 688	20 healthy volunteers, 20 patients with liver cirrhosis secondary to chronic hepatitis B (cirrhosis group), and 20 patients with small HCC secondary to cirrhosis liver parenchyma (HCC group)
T3	Participants 84 113	Patients With Liver Cirrhosis
